Comparing Cosmos Rx and Pharmacy Adherence for GERD
This study is comparing a new device called Fortiskap, which monitors how often you take your medication, with standard ways of tracking medication use based on pharmacy records. The study is for people aged 21 or older who have been diagnosed with GERD (Gastroesophageal Reflux Disease) or erosive esophagitis and are currently taking a once-daily oral PPI (like omeprazole or pantoprazole) for at least 30 days. The goal is to see if the Fortiskap device provides a more accurate picture of how well people are taking their medication compared to pharmacy fill data. The study plans to enroll 50 participants, but its current status is unclear.
- Study design
- This interventional study plans to enroll 50 participants. It compares the Fortiskap device with pharmacy fill adherence measures.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcomes of this study are measured at 90 days.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Comparison of Cosmos Rx Medication Adherence Platform vs. Pharmacy Fill Adherence Measures
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Abraham N Morse, MD, MBA · PRINCIPAL_INVESTIGATOR · Cosmos Rx, Inc
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Fortiskap vs. PDC adherence90 days
Comparison of medication adherence between Fortiskap™ tracking of prescription bottle opening and pharmacy fill data: The study measure is defined as the proportion of study days with at least one recorded medication removal event ("Fortiskap adherence rate") compared with the Proportion of Days Covered(PDC): the number of days during which pharmacy fill records demonstrate medication available divided by the number of study days. The primary comparison is a within subject paired analysis of continuous variables.
- Fortiskap vs. ARMS adherence comparison90 days
Comparison of medication adherence between Fortiskap™ tracking of prescription bottle opening and a validated adherence self-reporting tool: The study measure is defined as the proportion of study days with at least one recorded medication removal event ("Fortiskap adherence rate") compared with vs. Adherence to Refills and Medications Scale (ARMS) adherence self-reporting instrument.9 The primary comparison is a within subject paired analysis of the industry-standard dichotomous outcomes of 80% for daily medication consumption and \>=16 for the ARMS.